Comparison of Methylprednisolone Plus Prednisolone with Prednisolone Alone as Initial Treatment in Adult-Onset Minimal Change Disease | Zendy

Maki Shinzawa | Zendy; Ryohei Yamamoto | Zendy; Yasuyuki Nagasawa | Zendy; Susumu Oseto | Zendy; Daisuke Mori | Zendy; Kodo Tomida | Zendy; Terumasa Hayashi | Zendy; Masaaki Izumi | Zendy; Megumu Fukunaga | Zendy; Atsushi Yamauchi | Zendy; Yoshiharu Tsubakihara | Zendy; Yoshitaka Isaka | Zendy

Open Access

Comparison of Methylprednisolone Plus Prednisolone with Prednisolone Alone as Initial Treatment in Adult-Onset Minimal Change Disease

Author(s) -

Maki Shinzawa,

Ryohei Yamamoto,

Yasuyuki Nagasawa,

Susumu Oseto,

Daisuke Mori,

Kodo Tomida,

Terumasa Hayashi,

Masaaki Izumi,

Megumu Fukunaga,

Atsushi Yamauchi,

Yoshiharu Tsubakihara,

Yoshitaka Isaka

Publication year - 2014

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.12331213

Subject(s) - prednisolone , medicine , methylprednisolone , corticosteroid , adult onset still's disease , disease , surgery

Previous studies suggested that intravenous methylprednisolone possibly accelerates remission of proteinuria in adult-onset minimal change disease; its impact on relapse of proteinuria is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore